ClinicalTrials.gov
public full text
Public Domain
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
RATIONALE: Antifungal therapy with voriconazole or amphotericin B may be an effective treatment for aspergillosis. It is not yet known whether voriconazole is more effective than amphotericin B in treating patients with aspergillosis. PURPOSE: Randomized phase III trial to compare the effectiveness of voriconazole with amphotericin B in treating patients with aspergillosis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Individualisation of Voriconazole Antifungal Therapy Antifungal Therapy#1095281
- Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being#805772
- Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis#1111764
- Aspergillus and host-pathogen interaction: focus on treatment-relevant aspects#370631
- Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis#908117
Record · ID 1171793
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive